 BERKELEY, Calif., Sept. 27, 2021 GLOBE NEWSWIRE -- Caribou Biosciences, Inc. Nasdaq:CRBU, a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel Haurwitz, Ph.D., Caribous president and chief executive officer, will participate in a fireside chat on Monday, October 4, 2021, at 5:00 pm ET at the Chardan Virtual 5th Annual Genetic Medicines Conference. Dr. Haurwitz will also be part of a panel discussion: Gene Editing: Next-Generation Technologies Worth Watching on Tuesday, October 5, 2021, at 12:00pm ET. 